Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy

Authors

Kinan Alhallak, Washington University School of Medicine in St. Louis
Jennifer Sun, Washington University School of Medicine in St. Louis
Barbara Muz, Washington University School of Medicine in St. Louis
Amanda Jeske, Washington University School of Medicine in St. Louis
Julie O'Neal, Washington University School of Medicine in St. Louis
Julie K Ritchey, Washington University School of Medicine in St. Louis
Samuel Achilefu, Washington University School of Medicine in St. Louis
John F DiPersio, Washington University School of Medicine in St. Louis
Abdel Kareem Azab, Washington University School of Medicine in St. Louis

Journal

Journal of cellular and molecular medicine

Publication Date

2-1-2022

Volume

26

Issue

3

First Page

940

Last Page

944

Document Type

Open Access Publication

DOI

10.1111/jcmm.16885

Rights and Permissions

Alhallak, K, Sun, J, Muz, B, et al. Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy. J Cell Mol Med. 2022; 26: 940– 944. https://doi.org/10.1111/jcmm.16885 © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Alhallak, Kinan; Sun, Jennifer; Muz, Barbara; Jeske, Amanda; O'Neal, Julie; Ritchey, Julie K; Achilefu, Samuel; DiPersio, John F; and Azab, Abdel Kareem, "Liposomal phytohemagglutinin: In vivo T-cell activator as a novel pan-cancer immunotherapy." Journal of cellular and molecular medicine. 26, 3. 940 - 944. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11522